End-Stage Renal Disease: CMS Should Monitor Access to and Quality of Dialysis Care Promptly After Implementation of New Bundled Payment System
DIANE Publishing, 2011 - 72 pages
This is a print on demand edition of a hard to find publication. Medicare covers dialysis for most individuals with end-stage renal disease (ESRD). Beginning Jan. 2011, the Centers for Medicare and Medicaid Services (CMS) must use a single payment to pay for dialysis and related services, which include injectable ESRD drugs. What is this new payment system's effects on the access to and quality of dialysis care for certain groups of beneficiaries? This report examined: (1) Medicare expend. for injectable ESRD drugs, by demographic characteristics; (2) factors likely to result in above average doses of these drugs; (3) CMS's approach for addressing beneficiary differences in the cost of dialysis care under the new payment system; and (4) CMS's plans to monitor the new payment system's effects. Charts and tables.
What people are saying - Write a review
We haven't found any reviews in the usual places.
73 clinicians African American Appendix average doses beneficiaries on dialysis bundled payment system Chronic Kidney Disease clinical factors clinicians and researchers CMS officials costs of dialysis CROWNWeb data collection instrument database demographic characteristics dialysis care dialysis facilities dialysis in 2007 dialysis organizations dialysis services Dialysis-Related Drugs dialysis-related professional organizations Disease Prospective Payment Dose of Dialysis-Related doses of injectable End-Stage Renal Disease Erythropoietin ESRD patients ESRD researchers expenditures on injectable expenditures per beneficiary groups of beneficiaries hemodialysis hemoglobin higher-than Higher-Than-Average Dose Hyperparathyroidism implemented injectable ESRD drugs Instrument on Dose IV vitamin least 50 percent Levocarnitine Medicaid Medicare beneficiaries Medicare Part D Medicare’s monitoring the effects monthly Medicare expenditures nephrology clinicians outlier policy percent At least percent higher phosphate binders Prospective Payment System quality of dialysis race and ethnicity Renal Disease Prospective Residential location Selected Clinicians Socioeconomic status system for dialysis system on beneficiaries USRDS data vitamin vitamin D